期刊文献+

夜间酸突破 被引量:1

下载PDF
导出
摘要 夜间酸突破(nocturnal acid breakthrough,NAB)是litPeghini^[1]等学者于1998年提出,指在应用PPI的情况下夜间(当晚22时至次日早上8时)胃内pH〈4R持续时间超过60min的现象。十余年来国内外许多学者对此现象的临床意义、发生率、治疗等做了大量的研究,至今在许多问题上仍存在较大的争议。但NAB的发现。对指导酸相关性疾病的治疗具有重要意义,也有待我们进一步去研究探讨。
出处 《中国医药指南》 2012年第7期55-57,共3页 Guide of China Medicine
  • 相关文献

参考文献16

  • 1Peghini PL,Katz PO,Bracy NA,et al.Nocturnal recovery of gastricacid secretion with twice-daily dosing of p roton pump inhibitors[J].Am Gastroenterol,1998,93(5):763-767.
  • 2Peghini PL,Katz PO,Castell DO.Ranitidine controls nocturnalgastric acid breakthrough on omep razole:a controlled study innormal subjects[J].Gastroenterology,1998,115(6):1335-1339.
  • 3HongoM,Ohara S,Hirasawa Y,et al.Effect of lansop razole onintragastric pH.Comparison between morning and eveningdosing[J].Dig Dis Sci,1992,37(6):882-890.
  • 4Maton PN.Omep razole[J].N Engl J Med,1991,324(14):965-975.
  • 5Kinoshita Y,Kawanami C,Kishi K,et a1.Helicobacter pyloriindependent chronoIogicaI change in gastric acid secretion in theJapanese[J].Gut,1997,41(4):452-458.
  • 6Gillen D,Wirz AA,Ncichercut Wd,et al.Helicobacter pyloriinfection potentiates the inhibition of gastric acid secretion byOmeprazole[J].Gut,1999,44(3):468-475.
  • 7Shirai N,Furuta T,Xiao F,et al.Comparison of lansoprazole andfamotidine for gastric acid inhibition during the daytime andnighttime in different CYP2C19 genotype groups[J].AlimentPharmacol Ther,2002,16(7):837-846.
  • 8Klinkenberg-knol EC,Menwissen SG Combined gastric andoesophageal 24-hour pH monitoring and oesophageal S4-hourpH monitoring and oesophageal mananetry in patientswithretlux disease,resistant to treatment with omeprazole[J].AlimentPhaimacol Ther,1990,4(5):485-495.
  • 9Orr WC,Hamish MJ.The efficacy of omeprazole twice daily withsupplemental H2 blockade at bedtime in the suppression ofnocturnal oesophageal and gastric acidity[J].Aliment PharrnacolTher,2003,17(12):1553-1558.
  • 10Ouatu-Lascar R,Rebecaa C,Fitzgerald RC,et al.Differentiationand proliferation in Barrett’s esophagus and the effects of acidsuppression[J].Gastroenterology,1999,117(2):327-335.

二级参考文献59

  • 1张林,王江滨.CYP2C19与质子泵抑制剂[J].国外医学(消化系疾病分册),2004,24(3):166-169. 被引量:11
  • 2李骢,姜铀,李茹馨,姜春萌,姜妙娜,贾玉杰.十二指肠溃疡患者夜间酸突破现象临床研究[J].中国实用内科杂志,2004,24(12):725-727. 被引量:11
  • 3陈见南.消化性溃疡病及其治疗药物的昨天,今天和明天[J].中国医药情报,1995,1(3):164-167. 被引量:4
  • 4潘涛,王一平,刘芙成,吴宗英.睡前加服H_2-受体拮抗剂抑制夜间酸突破的系统评价[J].中国循证医学杂志,2006,6(6):416-420. 被引量:8
  • 5Pfefferkorm MD,Croffie JM,Gupta SK,et al.Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.J Pediatr Gastroenterol Nutr,2006,42:160-165.
  • 6Katsube T,Adachi K,Kawamura A,et al.Helieohacter pylori infetion influences nocturnal gastric acid breakthrough.Aliment Pharmacol Ther,2000,14:1049-1056.
  • 7Katz PO,Andderson C,Khoury R,et al.Gastro-esophageal reflux associated with nocturnal gastric acid hreakthrough on proton pump inhibitors.Aliment Pharmacol Ther,1998,12,1231-1234.
  • 8Xue S,Katz PO,Banerjee P,et al.Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.Aliment Pharmacol Ther,2001,15,1351-1356.
  • 9Orr WC,Harnish MJ.The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.Aliment Pharmacol Ther,2003,17= 1553-1558.
  • 10Ours TM,Fackler WT,Richter JE,et al.Nocturnal acid breakthrough:clinical significance and correlation with esophageal acid exposure.Am J Gastroenterol,2003,98:545-550.

共引文献73

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部